-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ja3b39Efw+CrVDZ8nTm95DifmZs/ylVQfgS32x9qNLP/Jspp6612b6xcXkMiiC0M 9k9zwRb56rLJc/aqvYqRbg== 0000950136-02-003469.txt : 20021212 0000950136-02-003469.hdr.sgml : 20021212 20021212163755 ACCESSION NUMBER: 0000950136-02-003469 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20021212 GROUP MEMBERS: JOHN TEEGER SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDIFAST INC CENTRAL INDEX KEY: 0000910329 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-FOOD STORES [5400] IRS NUMBER: 133714405 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-46282 FILM NUMBER: 02855973 BUSINESS ADDRESS: STREET 1: 11445 CRONHILL DRIVE CITY: OWINGS MILLS STATE: MD ZIP: 21117 BUSINESS PHONE: 7327640619 MAIL ADDRESS: STREET 1: 11445 CRONHILL DRIVE CITY: OWINGS MILLS STATE: MD ZIP: 21117 FORMER COMPANY: FORMER CONFORMED NAME: 00 DATE OF NAME CHANGE: 19950619 FORMER COMPANY: FORMER CONFORMED NAME: XX DATE OF NAME CHANGE: 19950619 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHRITE INC DATE OF NAME CHANGE: 19951120 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TEEGER JOHN L CENTRAL INDEX KEY: 0000925768 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: C/O FOUNDERS EQUITY INC STREET 2: 711 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2128290900 MAIL ADDRESS: STREET 1: C/O FOUNDERS EQUITY INC STREET 2: 711 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10022 SC 13D/A 1 file001.txt SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* MEDIFAST, INC. (fka HealthRite Inc.) - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, Par Value $0.001 Per Share - -------------------------------------------------------------------------------- (Title of Class of Securities) 42221F101 - -------------------------------------------------------------------------------- (CUSIP Number) Leo Silverstein, Esq. Reitler Brown LLC 800 Third Avenue, 21st floor New York, NY 10022 (212) 209-3050 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) June 26, 2002, July 9, 2002 and August 14, 2002 - -------------------------------------------------------------------------------- (Dates of Events Which Require Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ] Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss. 240.13d-7(b) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1
SCHEDULE 13D - --------------------------------------------------------------------------------------------------------------------------- CUSIP NO. 42221F101 PAGE 2 OF 7 PAGES---------- - ------------------------------------------------------------ -------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Warren H. Haber - --------------------------------------------------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A) [ ] (SEE INSTRUCTIONS) (B) [ ] - ---------------------------------------------------------------------------------------------------- ---------------------- 3 SEC USE ONLY - ------------------------------------------------------------ -------------------------------------------------------------- 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) PF - --------------------------------------------------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO [ ] ITEMS 2(D) OR 2(E) - ---------------------------------------------------------------------------------------- ---------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - --------------------------------------------------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF SHARES BENEFICIALLY OWNED -472,000- BY EACH REPORTING PERSON WITH 8 SHARED VOTING POWER -0- 9 SOLE DISPOSITIVE POWER -472,000- 10 SHARED DISPOSITIVE POWER -0- - --------------------------------------------------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -472,000- - --------------------------------------------------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN [ ] SHARES (SEE INSTRUCTIONS) - --------------------------------------------------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.9%, based upon 6,832,969 shares outstanding as of September 30, 2002, as reported in the Issuer's Quarterly Report on Form 10-QSB filed on November 4, 2002. - --------------------------------------------------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN
Page 2
SCHEDULE 13D - --------------------------------------------------------------------------------------------------------------------------- CUSIP NO. 42221F101 PAGE 2 OF 7 PAGES---------- - ------------------------------------------------------------ -------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) John L. Teeger - --------------------------------------------------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A) [ ] (SEE INSTRUCTIONS) (B) [ ] - --------------------------------------------------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------ -------------------------------------------------------------- 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) PF - --------------------------------------------------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO [ ] ITEMS 2(D) OR 2(E) - ---------------------------------------------------------------------------------------- ---------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - --------------------------------------------------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF SHARES -20,000- BENEFICIALLY OWNED BY EACH REPORTING 8 SHARED VOTING POWER PERSON WITH -0- 9 SOLE DISPOSITIVE POWER -20,000- 10 SHARED DISPOSITIVE POWER -0- - --------------------------------------------------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -20,000- - --------------------------------------------------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN [ ] SHARES (SEE INSTRUCTIONS) - --------------------------------------------------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.3%, based upon 6,832,969 shares outstanding as of September 30, 2002, as reported in the Issuer's Quarterly Report on Form 10-QSB filed on November 4, 2002. - --------------------------------------------------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN
Page 3 This Amendment No. 5 to Schedule 13D (as amended, the "Schedule 13D") relates to the beneficial ownership of shares of common stock, par value $0.001 per share ("Common Stock"), of Medifast, Inc., a Delaware corporation (formerly HealthRite Inc., and formerly Vitamin Specialties Corp.) (the "Company") and is being filed jointly by Warren H. Haber ("Mr. Haber") and John L. Teeger ("Mr. Teeger", and together with Mr. Haber, the "Reporting Persons") pursuant to a Joint Filing Agreement previously filed as Exhibit 1 to Amendment No. 4 to this Schedule 13D. The Reporting Persons disclaim "group" status with each other or any third party and each disclaims beneficial ownership of the shares of Common Stock of the Company beneficially owned by the other Reporting Person. This Amendment No. 5 to the Schedule 13D constitutes Mr. Teeger's close-out filing under Rule 13d-1 promulgated under the Securities Exchange Act of 1934, as amended. Any future amendments to this Schedule 13D shall be filed solely by and in respect of the beneficial ownership of Mr. Haber. ITEM 5. INTEREST IN THE SECURITIES OF THE COMPANY. Mr. Haber --------- (a) Mr. Haber is the direct beneficial owner of an aggregate of 472,000 shares of Common Stock. (b) Mr. Haber has sole power to vote and sole authority to dispose or direct the disposition of 472,000 shares of Common Stock. (c) Mr. Haber has not effected any transactions in the Common Stock since the filing of the last amendment to this Schedule 13D except that (i) on July 31, 2002, warrants to purchase 24,000 shares of Common Stock at an exercise price of $2.00 per share, previously beneficially owned by Mr. Haber, expired, (ii) in June 2002, the Company redeemed 4,375 shares of Series A Preferred Stock previously deemed beneficially owned by Mr. Haber, (iii) on August 14, 2002, he made a charitable contribution of 17,000 shares of Common Stock, and (iv) on August 6 and August 7, 2002, he sold in the NASD OTC Market in ordinary brokerages transactions an aggregate of 23,500 shares of Common Stock as follows: Date Share Price Number of Shares Sold ---- ----------- --------------------- August 6, 2002 $1.25 12,000 August 6, 2002 $1.24 2,000 August 7, 2002 $1.28 7,000 August 7, 2002 $1.27 2,500 (d) Mr. Haber owns and presently has the right to receive dividends from the shares of Common Stock owned by him. (e) Not Applicable. Mr. Teeger ---------- (a) Mr. Teeger is the beneficial owner of an aggregate of 20,000 shares of Common Stock. (b) Mr. Teeger has sole power to vote and sole authority to dispose or direct the disposition of 20,000 shares of Common Stock. (c) Mr. Teeger has not effected any transactions in the Common Stock since the filing of the last amendment to this Schedule 13D except as follows: (i) on July 31, 2002, warrants to purchase 24,000 shares of Common Stock at an exercise price of $2.00 per share, previously beneficially owned by Mr. Teeger, expired unexercised, (ii) in June 2002, the Company redeemed 3,750 shares of Series A Preferred Stock previously deemed beneficially owned by Mr. Teeger, and (iii) during the period from April 5, 2002 through November 25, 2002, he sold in the NASD OTC Market in ordinary brokerages transactions an aggregate of 292,700 shares of Common Stock of which 158,700 shares were sold after July 9, 2002 when Mr. Teeger ceased to be a 5% beneficial owner and of which 134,000 shares were sold between April 5, 2002 and July 9, 2002 as follows: Page 4 Date Share Price Number of Shares Sold - ---- ----------- --------------------- April 5, 2002 $ 0.82 5,000 April 9, 2002 $ 0.80 500 April 9, 2002 $ 0.80 4,500 April 11, 2002 $ 0.86 2,500 April 23, 2002 $ 0.81 5,000 April 24, 2002 $ 0.91 5,000 April 24, 2002 $0. 87 5,000 April 24, 2002 $0. 87 2,500 May 1, 2002 $0. 82 5,000 May 2, 2002 $0. 82 5,000 May 8, 2002 $0. 81 8,500 May 10, 2002 $0. 85 4,000 May 10, 2002 $0. 81 1,500 May 14, 2002 $0. 85 2,500 May 15, 2002 $0. 85 7,500 May 22, 2002 $0. 81 3,400 June 25, 2002 $0. 81 5,000 June 26, 2002 $0. 81 6,600 June 26, 2002 $0. 81 100 June 26, 2002 $0. 80 5,000 June 28, 2002 $0. 81 5,500 July 1, 2002 $0. 81 10,000 Jul 3, 2002 $0. 81 1,500 July 5, 2002 $0. 81 10,000 July 5, 2002 $0. 81 2,900 Page 5 July 5, 2002 $0. 81 10,000 July 8, 2002 $0. 81 7,500 July 9, 2002 $0. 81 2,500 (d) Mr. Teeger owns and presently has the right to receive dividends from the shares of Common Stock owned by him. (e) Mr. Teeger ceased to be the beneficial owner of 5% of the outstanding Common Stock of the Company on July 9, 2002. Page 6 SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: December 12, 2002 /s/ Warren H. Haber ------------------------------ Warren H. Haber /s/ John L. Teeger ------------------------------ John L. Teeger Page 7 -----END PRIVACY-ENHANCED MESSAGE-----